Marrone Bio Innovations to price initial public offering of stock

Jefferies, Piper Jaffray are bookrunners; Roth Capital, Stifel assist

By Devika Patel

Knoxville, Tenn., July 1 - Marrone Bio Innovations, Inc. plans to price an initial public offering of its common stock with a 30-day greenshoe, according to a Form S-1 filed Tuesday with the Securities and Exchange Commission. The company intends to list its common stock on the Nasdaq under the symbol "MBII."

Jefferies and Piper Jaffray are the joint bookrunning managers. Roth Capital Partners and Stifel are the co-managers.

Proceeds will be used to expand capacity at the company's manufacturing facility, for other capital expenditures, including purchasing equipment to facilitate our research and development efforts, for working capital and for other general corporate purposes.

Based in Davis, Calif., Marrone makes bio-based pest management and plant health products.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.